World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
18141
World Ranking
19460
National Ranking
653

Albert Tran publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Albert Tran sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 353 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Albert Tran D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Albert Tran sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 74 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Internal medicine, Gastroenterology, Cirrhosis, Surgery and Immunology are his primary areas of study. His Internal medicine research includes elements of Endocrinology and Hepatitis C virus. His research integrates issues of Liver biopsy, Hepatitis C, Fibrosis, Ribavirin and Cohort in his study of Gastroenterology.

The concepts of his Cirrhosis study are interwoven with issues in Telaprevir and Hepatology. The Surgery study combines topics in areas such as Octreotide and Radiology. In the subject of general Immunology, his work in Autoantibody is often linked to Hepatocyte, thereby combining diverse domains of study.

His most cited work include:

  • Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890 (384 citations)
  • Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASH (379 citations)
  • M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. (310 citations)

What are the main themes of his work throughout his whole career to date?

Albert Tran spends much of his time researching Internal medicine, Gastroenterology, Endocrinology, Immunology and Ribavirin. Internal medicine is closely attributed to Hepatitis C virus in his study. His Gastroenterology research incorporates themes from Hepatocellular carcinoma, Chronic hepatitis and Randomized controlled trial, Surgery.

While the research belongs to areas of Surgery, Albert Tran spends his time largely on the problem of Obesity, intersecting his research to questions surrounding C-reactive protein. Albert Tran focuses mostly in the field of Endocrinology, narrowing it down to matters related to Fatty liver and, in some cases, Pathogenesis. His study looks at the relationship between Insulin resistance and fields such as Metabolic syndrome, as well as how they intersect with chemical problems.

He most often published in these fields:

  • Internal medicine (76.90%)
  • Gastroenterology (51.27%)
  • Endocrinology (25.63%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (76.90%)
  • Gastroenterology (51.27%)
  • Cirrhosis (16.77%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Internal medicine, Gastroenterology, Cirrhosis, Hepatocellular carcinoma and Prospective cohort study. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Hepatitis C virus. His study on Hepatology is often connected to In patient as part of broader study in Gastroenterology.

He works mostly in the field of Cirrhosis, limiting it down to topics relating to Liver disease and, in certain cases, Alcoholic liver disease. He has researched Prospective cohort study in several fields, including Bioelectrical impedance analysis and Anxiety. His work focuses on many connections between Surgery and other disciplines, such as Obesity, that overlap with his field of interest in Renal function.

Between 2015 and 2021, his most popular works were:

  • Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications (258 citations)
  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study (179 citations)
  • Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs (90 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

His main research concerns Internal medicine, Gastroenterology, Cirrhosis, Hepatocellular carcinoma and Hepatitis C. His Internal medicine study frequently links to related topics such as Immunology. His Gastroenterology research is multidisciplinary, relying on both Regimen, Randomized controlled trial, Surgery and Hepatitis C virus.

His Cirrhosis research includes elements of Liver cancer, Prospective cohort study and Transplantation. The various areas that Albert Tran examines in his Hepatocellular carcinoma study include Carcinoma, Hepatology and Hepatitis B virus. His Hepatitis C research includes themes of Survival rate and Liver transplantation.

Best Publications

  • Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASH

    Soumeya Bekri;Philippe Gual;Rodolphe Anty;Rodolphe Anty;Nathalie Luciani

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

    Pierre Nahon;Pierre Nahon;Valérie Bourcier;Richard Layese;Etienne Audureau

  • Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890

    Christophe Hézode;Hélène Fontaine;Céline Dorival;Dominique Larrey

  • M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.

    Jinghong Wan;Merieme Benkdane;Fatima Teixeira-Clerc;Stéphanie Bonnafous

  • Identification of Adipose Tissue Dendritic Cells Correlated With Obesity-Associated Insulin-Resistance and Inducing Th17 Responses in Mice and Patients

    Adeline Bertola;Adeline Bertola;Thomas Ciucci;Thomas Ciucci;Déborah Rousseau;Déborah Rousseau;Virginie Bourlier;Virginie Bourlier

  • Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

    Marc Bourlière;Jean Pierre Bronowicki;Victor de Ledinghen;Christophe Hézode

  • ER stress induces NLRP3 inflammasome activation and hepatocyte death.

    C Lebeaupin;C Lebeaupin;E Proics;E Proics;C H D de Bieville;C H D de Bieville;D Rousseau;D Rousseau

  • Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

    Christophe Hézode;Helene Fontaine;Celine Dorival;Fabien Zoulim

  • High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

    Albert Tran;Jean François Quaranta;Sylvia Benzaken;Valerie Thiers

  • Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.

    T Piche;M C Saint-Paul;R Dainese;E Marine-Barjoan

  • Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study

    Jean-Pierre Zarski;Nathalie Sturm;Jérôme Guechot;Adeline Paris

  • Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.

    Jean–Pierre Bronowicki;Denis Ouzan;Tarik Asselah;Hervé Desmorat

  • Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients

    Adeline Bertola;Adeline Bertola;Stéphanie Bonnafous;Stéphanie Bonnafous;Rodolphe Anty;Rodolphe Anty;Stéphanie Patouraux

  • Obesity dependent metabolic signatures associated with nonalcoholic fatty liver disease progression

    Barr J;Caballería J;Martínez-Arranz I;Domínguez-Díez A

  • The Inflammatory C-Reactive Protein is Increased in Both Liver and Adipose Tissue in Severely Obese Patients Independently from Metabolic Syndrome, Type 2 Diabetes, and NASH

    Rodolphe Anty;Soumeya Bekri;Nathalie Luciani;Marie-Christine Saint-Paul

  • Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus.

    Philippe Halfon;Marc Bourlière;Guillaume Pénaranda;Romaric Deydier

  • Liquid Chromatography−Mass Spectrometry-Based Parallel Metabolic Profiling of Human and Mouse Model Serum Reveals Putative Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver Disease

    Jonathan Barr;Mercedes Vázquez-Chantada;Cristina Alonso;Miriam Pérez-Cormenzana

  • Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study

    Philippe Halfon;Marc Bourliere;Romaric Deydier;Danielle Botta-Fridlund

  • Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C

    Philippe Halfon;Yannick Bacq;Anne De Muret;Guillaume Penaranda

Frequent Co-Authors

Marc Bourlière
Marc Bourlière Hôpital Saint Joseph
Jean-Pierre Bronowicki
Jean-Pierre Bronowicki University Hospital of Nancy
Stanislas Pol
Stanislas Pol Université Paris Cité
Dominique Larrey
Dominique Larrey University of Montpellier
Laurent Alric
Laurent Alric Federal University of Toulouse Midi-Pyrénées
Victor de Ledinghen
Victor de Ledinghen Grenoble Alpes University
Christophe Hézode
Christophe Hézode Université Paris Cité
Paul Calès
Paul Calès University of Angers
Patrick Marcellin
Patrick Marcellin Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring diverse avenues within healthcare, a wide range of online degrees and certifications now make career advancement more accessible than ever. Professionals looking to deepen their clinical expertise might consider msn to dnp programs online, which offer a flexible route to obtaining a Doctor of Nursing Practice.

Those interested in pharmacy can benefit from pharm d online programs that prepare students for advanced clinical roles while balancing work and study.

Not all healthcare careers are patient-facing; managing medical data is critical to the system’s success. An health information management degree online is ideal for those seeking leadership positions in organizing and safeguarding patient records.

For students wishing to quickly enter the workforce, earning a medical billing and coding certification online may open doors to administrative roles in hospitals, insurance companies, or medical offices.

These online options offer convenience, affordability, and a pathway to a wide array of in-demand healthcare professions.

Best Scientists Citing Albert Tran

Trending Scientists

Recently Published Articles